ABOUT THE RESEARCHER

OVERVIEW

Economic evaluations of clinical interventions, health care policies and programs Experience with cost, cost effectiveness and cost-of-illness analysis Statistical analysis (SAS, STATA) & economic modelling (TreeAge, Excel) Collection and analysis of patient-reported outcomes (HRQL and non-health care costs) Consult research investigators and clinicians from study concept to publication of results; mentor junior investigators

BACKGROUND

Mihail Samnaliev has 15 years of experience with economic evaluations, health economics and outcomes research, and statistical analysis. He consults research investigators and clinicians from study concept to publication of results. Over the past 15 years he has been the lead economist for a number of studies evaluating clinical interventions, health care policies and programs and has supervised or conducted the statistical analyses of numerous observational studies. He is an Assistant Professor at Harvard Medical School.

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. 2021; 5(3):rkab071. View abstract
  2. Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical Trial. JAMA. 2021 09 07; 326(9):839-850. View abstract
  3. Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. 2021; 5(3):rkab061. View abstract
  4. Social and economic cost of eating disorders in the United States: Evidence to inform policy action. Int J Eat Disord. 2021 05; 54(5):851-868. View abstract
  5. Developing a Database of Structural Racism-Related State Laws for Health Equity Research and Practice in the United States. Public Health Rep. 2021 Jul-Aug; 136(4):428-440. View abstract
  6. Pediatric Primary Care-Based Social Needs Services and Health Care Utilization. Acad Pediatr. 2021 Nov-Dec; 21(8):1331-1337. View abstract
  7. Seeking racial and ethnic equity among neonatologists. J Perinatol. 2021 03; 41(3):422-434. View abstract
  8. Equity for women in medicine-neonatologists identify issues. J Perinatol. 2021 03; 41(3):435-444. View abstract
  9. Reduction in Resources and Cost for Gastroenteritis Through Implementation of Dehydration Pathway. Pediatrics. 2020 07; 146(1). View abstract
  10. Persistent postoperative pain and healthcare costs associated with instrumented and non-instrumented spinal surgery: a case-control study. J Orthop Surg Res. 2020 Apr 01; 15(1):127. View abstract
  11. The association of disordered eating with health-related quality of life in U.S. young adults and effect modification by gender. Qual Life Res. 2020 May; 29(5):1203-1215. View abstract
  12. Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study. Future Cardiol. 2019 09; 15(5):367-375. View abstract
  13. Trends in Visits and Costs for Mental Health Emergencies in a Pediatric Emergency Department, 2010-2016. Acad Pediatr. 2019 May - Jun; 19(4):386-393. View abstract
  14. Reoperation following lumbar spinal surgery: costs and outcomes in a UK population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). Eur Spine J. 2019 04; 28(4):863-871. View abstract
  15. Analysis of Healthcare Institutional Costs of Pediatric Home Parenteral Nutrition Central Line Infections. J Pediatr Gastroenterol Nutr. 2018 10; 67(4):e77-e81. View abstract
  16. Under-recording of hospital bleeding events in UK primary care: a linked Clinical Practice Research Datalink and Hospital Episode Statistics study. Clin Epidemiol. 2018; 10:1155-1168. View abstract
  17. Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity. Obes Surg. 2018 08; 28(8):2203-2214. View abstract
  18. Sexual orientation-related disparities in employment, health insurance, healthcare access and health-related quality of life: a cohort study of US male and female adolescents and young adults. BMJ Open. 2018 07 26; 8(6):e020418. View abstract
  19. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK. Mov Disord. 2018 Jul; 33(6):974-981. View abstract
  20. Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity. Surg Obes Relat Dis. 2018 07; 14(7):1041-1059. View abstract
  21. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). BMJ Open. 2017 Sep 11; 7(9):e017585. View abstract
  22. Stigma and Health-Related Quality of Life in Sexual Minorities. Am J Prev Med. 2017 Oct; 53(4):559-566. View abstract
  23. Impact of standardized clinical assessment and management plans on resource utilization and costs in children after the arterial switch operation. Congenit Heart Dis. 2017 Dec; 12(6):768-776. View abstract
  24. The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned. Contemp Clin Trials. 2017 09; 60:14-23. View abstract
  25. Decrements in health-related quality of life associated with gender nonconformity among U.S. adolescents and young adults. Qual Life Res. 2017 08; 26(8):2129-2138. View abstract
  26. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895. View abstract
  27. Technical Performance Score Predicts Resource Utilization in Congenital Cardiac Procedures. J Am Coll Cardiol. 2016 06 07; 67(22):2696-8. View abstract
  28. Variation and Trends in Charges for Pediatric Care in Massachusetts Emergency Departments, 2000-2011. Acad Emerg Med. 2015 Oct; 22(10):1164-71. View abstract
  29. Quality Improvement Effort to Reduce Cranial CTs for Children With Minor Blunt Head Trauma. Pediatrics. 2015 Jul; 136(1):e227-33. View abstract
  30. The utility of the DDAVP challenge test in children with low von Willebrand factor. Br J Haematol. 2015 Sep; 170(6):884-6. View abstract
  31. Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model. J Med Econ. 2015 Jun; 18(6):410-9. View abstract
  32. Cost-effectiveness of Adolescent Bariatric Surgery. Cureus. 2015 Feb; 7(2):e248. View abstract
  33. Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program. Subst Abus. 2015; 36(2):174-82. View abstract
  34. The economic burden of eating disorders and related mental health comorbidities: An exploratory analysis using the U.S. Medical Expenditures Panel Survey. Prev Med Rep. 2015; 2:32-4. View abstract
  35. The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life. Value Health. 2014 Nov; 17(7):A331. View abstract
  36. Cost-effectiveness of a disease management program for early childhood caries. J Public Health Dent. 2015; 75(1):24-33. View abstract
  37. Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics. 2014 Jan; 133(1):e227-34. View abstract
  38. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth. 2013 Nov; 23(11):1027-34. View abstract
  39. On the cost-effectiveness of the use of probiotics in inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):473. View abstract
  40. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff (Millwood). 2011 Aug; 30(8):1425-33. View abstract
  41. Factors associated with Medicaid patients' access to buprenorphine treatment. J Subst Abuse Treat. 2011 Jul; 41(1):88-96. View abstract
  42. Racial/ethnic disparities in mental health treatment in six Medicaid programs. J Health Care Poor Underserved. 2009 Feb; 20(1):165-76. View abstract
  43. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009 Jan; 60(1):35-42. View abstract
  44. The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatr Serv. 2009 Jan; 60(1):43-9. View abstract
  45. Comparative evaluation of two asthma care quality measures among Medicaid beneficiaries. Chest. 2009 May; 135(5):1193-1196. View abstract
  46. Patterns of health care utilization for asthma treatment in adults with substance use disorders. J Addict Med. 2008 Jun; 2(2):79-84. View abstract
  47. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatr Serv. 2007 Jul; 58(7):942-8. View abstract
  48. Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant model. Psychiatr Serv. 2007 Jul; 58(7):949-54. View abstract
  49. Psychosocial treatment in the 21st century. Int J Law Psychiatry. 2005 Sep-Oct; 28(5):532-44. View abstract